Second Quarter 2026 Financial Results & Business Update JULY 28, 2026 Agenda 01 Introduction Alexis Smith | VP, Investor Relations 04 03 R&D Highlights Pablo Cagnoni, M.D. | President and Global Head of R&D Financial Results Suky Upadhyay | EVP, Chief Financial Officer 06 02 Commercial Business Performance Bill Meury | Chief Executive Officer 05 Closing Remarks Bill Meury | Chief Executive Officer Q&A Steven Stein, M.D. | EVP, Chief Medical Officer and Head of Late-Stage Development Dave Gardner | EVP, Chie ...